These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1402 related articles for article (PubMed ID: 25869964)
21. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy. Wu G; Wang Z; Bian X; Du X; Wei C Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652 [TBL] [Abstract][Full Text] [Related]
22. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo. Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757 [TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
24. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity. Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899 [TBL] [Abstract][Full Text] [Related]
25. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229 [TBL] [Abstract][Full Text] [Related]
26. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551 [TBL] [Abstract][Full Text] [Related]
27. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
30. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550 [TBL] [Abstract][Full Text] [Related]
31. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia. Gaber MH J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965 [TBL] [Abstract][Full Text] [Related]
32. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031 [TBL] [Abstract][Full Text] [Related]
33. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
34. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818 [TBL] [Abstract][Full Text] [Related]
35. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007 [TBL] [Abstract][Full Text] [Related]
36. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. Ling L; Ismail M; Du Y; Yao C; Li X Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133 [TBL] [Abstract][Full Text] [Related]
37. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates. Canal F; Vicent MJ; Pasut G; Schiavon O J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587 [TBL] [Abstract][Full Text] [Related]
38. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release. Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095 [TBL] [Abstract][Full Text] [Related]
39. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity. Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948 [TBL] [Abstract][Full Text] [Related]
40. Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats. Gaspar MM; Radomska A; Gobbo OL; Bakowsky U; Radomski MW; Ehrhardt C J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):310-8. PubMed ID: 22857016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]